|
|
|
|
| LEADER |
00893cz a2200229n 4500 |
| 001 |
mzk2014842170 |
| 003 |
CZ PrNK |
| 005 |
20141013150714.0 |
| 008 |
141007|n|acnnnaabn n a|a |
| 040 |
|
|
|a BOA001
|b cze
|
| 046 |
|
|
|f 1956
|
| 100 |
1 |
|
|a Copeland, Robert Allen,
|d 1956-
|7 mzk2014842170
|
| 670 |
|
|
|a Copeland, Robert A.: Evaluation of enzyme inhibitors in drug discovery, 2013
|
| 670 |
|
|
|a LC (Names), cit. 7. 10. 2014
|b autoritní forma, datum narození
|
| 670 |
|
|
|a BNF, cit. 7. 10. 2014
|b národnost
|
| 670 |
|
|
|a www(Case Western Reserve University), cit. 7. 10. 2014
|b biografické údaje
|
| 678 |
0 |
|
|a Americký farmakolog.
|
| 906 |
|
|
|a za20141007
|b horaiv
|
| 906 |
|
|
|a ko20141013
|b veleja
|
| 906 |
|
|
|a oz20141013
|b veleja
|c Záhlaví - datum narození
|
| 991 |
0 |
|
|a Copeland, Robert Allen
|7 mzk2014842170
|
| 998 |
|
|
|a http://aleph.nkp.cz/F/?func=direct&doc_number=000842170&local_base=AUT
|
